"Immunotherapy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection.
Descriptor ID |
D007167
|
MeSH Number(s) |
E02.095.465.425
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Immunotherapy".
Below are MeSH descriptors whose meaning is more specific than "Immunotherapy".
This graph shows the total number of publications written about "Immunotherapy" by people in this website by year, and whether "Immunotherapy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1999 | 0 | 1 | 1 |
2002 | 1 | 0 | 1 |
2003 | 4 | 2 | 6 |
2005 | 2 | 0 | 2 |
2006 | 1 | 0 | 1 |
2007 | 0 | 1 | 1 |
2008 | 2 | 0 | 2 |
2010 | 3 | 2 | 5 |
2011 | 3 | 1 | 4 |
2012 | 0 | 1 | 1 |
2013 | 3 | 1 | 4 |
2014 | 0 | 2 | 2 |
2015 | 0 | 4 | 4 |
2016 | 4 | 1 | 5 |
2017 | 5 | 2 | 7 |
2018 | 4 | 7 | 11 |
2019 | 3 | 3 | 6 |
2020 | 6 | 7 | 13 |
2021 | 3 | 7 | 10 |
2022 | 2 | 11 | 13 |
2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Immunotherapy" by people in Profiles.
-
Advances in diagnosis and treatment of bladder cancer. BMJ. 2024 02 12; 384:e076743.
-
Therapeutic Landscape Beyond Immunotherapy in Advanced Urothelial Carcinoma: Moving Past the Checkpoint. Drugs. 2022 Nov; 82(17):1649-1662.
-
Subcellular location of source proteins improves prediction of neoantigens for immunotherapy. EMBO J. 2022 12 15; 41(24):e111071.
-
Primary squamous cell carcinoma of the thyroid treated with concurrent chemoradiation and palliative immunotherapy: a case report. J Med Case Rep. 2022 Oct 05; 16(1):364.
-
Localized ablative immunotherapy drives de novo CD8+ T-cell responses to poorly immunogenic tumors. J Immunother Cancer. 2022 Oct; 10(10).
-
Immune Checkpoint Inhibitors: The Unexplored Landscape of Geriatric Oncology. Oncologist. 2022 Sep 02; 27(9):778-789.
-
Targeting thymidine phosphorylase alleviates resistance to dendritic cell immunotherapy in colorectal cancer and promotes antitumor immunity. Front Immunol. 2022; 13:988071.
-
Analysis of Association of Radiation Therapy With Risk of Adverse Events in Patients Receiving Immunotherapy Using Pooled Trial Data Matched by Propensity Score. JAMA Oncol. 2022 Jul 01; 8(7):1072.
-
Multimodal Tracking of Theranostic Nanoparticles with CAR T Immunotherapy for Non-Hodgkin Lymphoma. Radiol Imaging Cancer. 2022 07; 4(4):e229015.
-
Differential prognostic effect of systemic inflammation in patients with non-small cell lung cancer treated with immunotherapy or chemotherapy: A post hoc analysis of the phase 3 OAK trial. Cancer. 2022 08 15; 128(16):3067-3079.